Skip to main
IVVD
IVVD logo

Invivyd Inc (IVVD) Stock Forecast & Price Target

Invivyd Inc (IVVD) Analyst Ratings

Based on 5 analyst ratings
Strong Buy
Strong Buy 60%
Buy 40%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

Invivyd Inc. has successfully closed a $57.5 million public offering, which enhances its financial position and extends its funding runway for ongoing development programs. The company's focus on innovative antibody solutions, specifically its candidates ADG20 and VYD222, is strategically aligned with addressing the evolving challenges posed by viral diseases, particularly COVID-19. Additionally, rolling forward valuation metrics from the end of 2025 to 2026 has led to a positive adjustment in projected value, indicating a promising outlook for the company's financial performance moving forward.

Bears say

Invivyd has recently experienced a significant reduction in expectations related to its market share for PEMGARDA within the immunocompromised patient segment, which suggests potential challenges in capturing market demand. Additionally, a capital raise has led to increased dilution, further exacerbating concerns about the company’s financial position, as reflected in a lowered price target from $3.00 to $1.00. Such developments indicate heightened risk factors for investors, casting a negative outlook on Invivyd's stock performance moving forward.

Invivyd Inc (IVVD) has been analyzed by 5 analysts, with a consensus rating of Strong Buy. 60% of analysts recommend a Strong Buy, 40% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Invivyd Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Invivyd Inc (IVVD) Forecast

Analysts have given Invivyd Inc (IVVD) a Strong Buy based on their latest research and market trends.

According to 5 analysts, Invivyd Inc (IVVD) has a Strong Buy consensus rating as of Oct 29, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $5.91, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $5.91, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Invivyd Inc (IVVD)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.